Synthesis and Evaluation of the Antiviral Activity of 5-Halogen-2'-Azido-Substituted Derivatives of Cytidine and N-Hydroxycytidine on a Panel of RNA Viruses, Including SARS-CoV-2
- Autores: Kamzeeva P.N.1, Kozlovskaya L.I.2,3, Belyaev E.S.4, Chistov A.A.1, Alferova V.A.1, Yakovchuk E.V.2,3, Borodulina M.O.2,3, Karpova E.V.2, Kolpakova E.S.2, Aralov A.V.3
- 
							Afiliações: 
							- Institute of Bioorganic Chemistry, Russian Academy of Sciences
- Chumakov Scientific Center for Research and Development of Immune-and-Biological Products, Russian Academy of Sciences (Institute of Poliomyelitis), village of the Institute of Poliomyelitis
- Sechenov First Moscow State Medical University
- Frumkin Institute of Physical Chemistry and Electrochemistry, Russian Academy of Science
 
- Edição: Volume 49, Nº 6 (2023)
- Páginas: 657-664
- Seção: ПИСЬМА РЕДАКТОРУ
- URL: https://cardiosomatics.ru/0132-3423/article/view/670554
- DOI: https://doi.org/10.31857/S0132342323060064
- EDN: https://elibrary.ru/PMYJGZ
- ID: 670554
Citar
Texto integral
 Acesso aberto
		                                Acesso aberto Acesso está concedido
						Acesso está concedido Acesso é pago ou somente para assinantes
		                                							Acesso é pago ou somente para assinantes
		                                					Resumo
Coronavirus disease 2019 (COVID-19) is a new global pandemic with high morbidity and mortality caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). N-Hydroxycytidine derivatives show promise for combating viral diseases, and in particular, molnupiravir has recently been approved for emergency prophylaxis in the early stages after infection with SARS-CoV-2. Here, a scheme for the synthesis of 5‑halo-2'-azido-substituted derivatives of cytidine and N-hydroxycytidine is proposed. The synthesized compounds were tested on a panel of six RNA viruses, including SARS-CoV-2, enteroviruses, CHIKV, and HIV-1. A number of compounds were able to inhibit the reproduction of SARS-CoV-2 and CHIKV viruses in the micromolar range without noticeable cytotoxicity. The structures of the leader compounds can be used as a starting point for further design of antiviral agents.
Palavras-chave
Sobre autores
P. Kamzeeva
Institute of Bioorganic Chemistry, Russian Academy of Sciences
														Email: Baruh238@mail.ru
				                					                																			                												                								Russia, 117997, Moscow, ul. Miklukho-Maklaya 16/10						
L. Kozlovskaya
Chumakov Scientific Center for Research and Development of Immune-and-Biological Products, Russian Academyof Sciences (Institute of Poliomyelitis), village of the Institute of Poliomyelitis; Sechenov First Moscow State Medical University
														Email: Baruh238@mail.ru
				                					                																			                												                								Russia, 108819, Moscow, settlement Moskovskiy, 8/1; Russia, 119991, Moscow, ul. Trubetskaya 8/2						
E. Belyaev
Frumkin Institute of Physical Chemistry and Electrochemistry, Russian Academy of Science
														Email: Baruh238@mail.ru
				                					                																			                												                								Russia, 119071, Moscow, Leninskiy prosp. 31						
A. Chistov
Institute of Bioorganic Chemistry, Russian Academy of Sciences
														Email: Baruh238@mail.ru
				                					                																			                												                								Russia, 117997, Moscow, ul. Miklukho-Maklaya 16/10						
V. Alferova
Institute of Bioorganic Chemistry, Russian Academy of Sciences
														Email: Baruh238@mail.ru
				                					                																			                												                								Russia, 117997, Moscow, ul. Miklukho-Maklaya 16/10						
E. Yakovchuk
Chumakov Scientific Center for Research and Development of Immune-and-Biological Products, Russian Academyof Sciences (Institute of Poliomyelitis), village of the Institute of Poliomyelitis; Sechenov First Moscow State Medical University
														Email: Baruh238@mail.ru
				                					                																			                												                								Russia, 108819, Moscow, settlement Moskovskiy, 8/1; Russia, 119991, Moscow, ul. Trubetskaya 8/2						
M. Borodulina
Chumakov Scientific Center for Research and Development of Immune-and-Biological Products, Russian Academyof Sciences (Institute of Poliomyelitis), village of the Institute of Poliomyelitis; Sechenov First Moscow State Medical University
														Email: Baruh238@mail.ru
				                					                																			                												                								Russia, 108819, Moscow, settlement Moskovskiy, 8/1; Russia, 119991, Moscow, ul. Trubetskaya 8/2						
E. Karpova
Chumakov Scientific Center for Research and Development of Immune-and-Biological Products, Russian Academyof Sciences (Institute of Poliomyelitis), village of the Institute of Poliomyelitis
														Email: Baruh238@mail.ru
				                					                																			                												                								Russia, 108819, Moscow, settlement Moskovskiy, 8/1						
E. Kolpakova
Chumakov Scientific Center for Research and Development of Immune-and-Biological Products, Russian Academyof Sciences (Institute of Poliomyelitis), village of the Institute of Poliomyelitis
														Email: Baruh238@mail.ru
				                					                																			                												                								Russia, 108819, Moscow, settlement Moskovskiy, 8/1						
A. Aralov
Sechenov First Moscow State Medical University
							Autor responsável pela correspondência
							Email: Baruh238@mail.ru
				                					                																			                												                								Russia, 119991, Moscow, ul. Trubetskaya 8/2						
Bibliografia
- Holmes E.C., Goldstein S.A., Rasmussen A.L., Robertson D.L., Crits-Christoph A., Wertheim J.O., Anthony S.J., Barclay W.S., Boni M.F., Doherty P.C., Farrar J., Geoghegan J.L., Jiang X., Leibowitz J.L., Neil S.J.D., Skern T., Weiss S.R., Worobey M., Andersen K.G., Garry R.F., Rambaut A. // Cell. 2021. V. 184. P. 4848–4856. https://doi.org/10.1016/j.cell.2021.08.017
- Triggle C.R., Bansal D., Ding H., Islam M.M., Farag E.A.B.A., Hadi H.A., Sultan A.A. // Front. Immunol. 2021. V. 12. P. 631139. https://doi.org/10.3389/fimmu.2021.631139
- van de Leemput J., Han Z. // Mol. Cell. Biol. 2021. V. 41. P. 1–16. https://doi.org/10.1128/MCB.00185-21
- Khudhair Z.T., Shihab M.S., Hamah-Ameen B. // Russ. J. Bioorg. Chem. 2021. V. 47. P. 789–804. https://doi.org/10.1134/S1068162021040130
- Beigel J.H., Tomashek K.M., Dodd L.E., Mehta A.K., Zingman B.S., Kalil A.C., Hohmann E., Chu H.Y., Luetkemeyer A., Kline S., de Castilla D.L., Finberg R.W., Dierberg K., Tapson V., Hsieh L., Patterson T.F., Paredes R., Sweeney D.A., Short W.R., Touloumi G., Lye D.C., Ohmagari N., Oh M.-D., Ruiz-Palacios G.M., Benfield T., Fätkenheuer G., Kortepeter M.G., Atmar R.L., Creech C.B., Lundgren J., Babiker A.G., Pett S., Neaton J.D., Burgess T.H., Bonnett T., Green M., Makowski M., Osinusi A., Nayak S., Lane H.C. // N. Engl. J. Med. 2020. V. 383. P. 1813–1826. https://doi.org/10.1056/NEJMoa2007764
- Zhou S., Hill C.S., Sarkar S., Tse L.V., Woodburn B.M.D., Schinazi R.F., Sheahan T.P., Baric R.S., Heise M.T., Swanstrom R. // J. Infect. Dis. 2021. V. 224. P. 415–419. https://doi.org/10.1093/infdis/jiab247
- Amblard F., LeCher J.C., De R., Goh S.L., Li C., Kasthuri M., Biteau N., Zhou L., Tber Z., Downs-Bowen J., Zandi K., Schinazi R.F. // Pharmaceuticals 2022. V. 15. P. 1144. https://doi.org/10.3390/ph15091144
- Urakova N., Kuznetsova V., Crossman D.K., Sokratian A., Guthrie D.B., Kolykhalov A.A., Lockwood M.A., Natchus M.G., Crowley M.R., Painter G.R., Frolova E.I., Frolov I. // J. Virol. 2018. V. 92. P. e01965-17. https://doi.org/10.1128/JVI.01965-17
- Agostini M.L., Pruijssers A.J., Chappell J.D., Gribble J., Lu X., Andres E.L., Bluemling G.R., Lockwood M.A., Sheahan T.P., Sims A.C., Natchus M.G., Saindane M., Kolykhalov A.A., Painter G.R., Baric R.S., Denison M.R. // J. Virol. 2019. V. 93. P. e01348-19. https://doi.org/10.1128/JVI.01348-19
- Kabinger F., Stiller C., Schmitzová J., Dienemann C., Kokic G., Hillen H.S., Höbartner C., Cramer P. // Nat. Struct. Mol. Biol. 2021. V. 28. P. 740–746. https://doi.org/10.1038/s41594-021-00651-0
- Liu F., Chen H.-M., Armstrong Z., Withers S.G. // ACS Cent. Sci. 2022. V. 8. P. 656–662. https://doi.org/10.1021/acscentsci.1c01172
- Chen F.-F., Wang F. // Molecules 2009. V. 14. P. 2656–2668. https://doi.org/10.3390/molecules14072656
- Wnuk S.F., Chowdhury S.M., Garcia P.I., Robins M.J. // J. Org. Chem. 2002. V. 67. P. 1816–1819. https://doi.org/10.1021/jo010899i
- Fedeles B.I., Freudenthal B.D., Yau E., Singh V., Chang S., Li D., Delaney J.C., Wilson S.H., Essigmann J.M. // Proc. Natl. Acad. Sci. USA. 2015. V. 112. P. 4571–4580. https://doi.org/10.1073/pnas.1507709112
- Moffatt J.G., Verheyden J.P.H., Wagner D. // J. Org. Chem. 1971. V. 36. P. 250–254. https://doi.org/10.1021/jo00801a002
- Asakura J., Robins M.J. // J. Org. Chem. 1990. V. 55. P. 4928–4933. https://doi.org/10.1021/jo00303a033
- McGee D.P.C., Vargeese C., Zhai Y.S., Kirschenheuter G.P., Settle A., Siedem C.R., Pieken W.A. // Nucleosides and Nucleotides. 1995. V. 14. P. 1329–1339. https://doi.org/10.1080/15257779508010694
- Mieczkowski A., Wińska P., Kaczmarek M., Mroczkowska M., Garbicz D., Pilżys T., Marcinkowski M., Piwowarski J., Grzesiuk E. // Chem. Pap. 2018. V. 72. P. 981–990. https://doi.org/10.1007/s11696-017-0339-9
- Paymode D.J., Vasudevan N., Ahmad S., Kadam A.L., Cardoso F.S.P., Burns J.M., Cook D.W., Stringham R.W., Snead D.R. // Org. Process Res. Dev. 2021. V. 25. P. 1822–1830. https://doi.org/10.1021/acs.oprd.1c00219
- Sheahan T.P., Sims A.C., Zhou S., Graham R.L., Pruijssers A.J., Agostini M.L., Leist S.R., Schäfer A., Dinnon K.H., Stevens L.J., Chappell J.D., Lu X., Hughes T.M., George A.S., Hill C.S., Montgomery S.A., Brown A.J., Bluemling G.R., Natchus M.G., Saindane M., Kolykhalov A.A., Painter G., Harcourt J., Tamin A., Thornburg N.J., Swanstrom R., Denison M.R., Baric R.S. // Sci. Transl. Med. 2020. V. 12. P. eabb5883. https://doi.org/10.1126/scitranslmed.abb5883
- Mitsuya H., Weinhold K.J., Furman P.A., St Clair M.H., Lehrman S.N., Gallo R.C., Bolognesi D., Barry D.W., Broder S. // Proc. Natl. Acad. Sci. USA. 1985. V. 82. P. 7096–7100. https://doi.org/10.1073/pnas.82.20.7096
- Fischl M.A., Richman D.D., Grieco M.H., Gottlieb M.S., Volberding P.A., Laskin O.L., Leedom J.M., Groopman J.E., Mildvan D., Schooley R.T., Jackson G.G., Durack D.T., King D. // N. Engl. J. Med. 1987. V. 317 P. 185–191. https://doi.org/10.1056/NEJM198707233170401
- Kozlovskaya L.I., Volok V.P., Shtro A.A., Nikolaeva Y.V., Chistov A.A., Matyugina E.S., Belyaev E.S., Jegorov A.V., Snoeck R., Korshun V.A., Andrei G., Osolodkin D.I., Ishmukhametov A.A., Aralov A.V. // Eur. J. Med. Chem. 2021. V. 220. P. 113467. https://doi.org/10.1016/j.ejmech.2021.113467
- Kärber G. // Arch. Exp. Pathol. Pharmakol. 1931. V. 162. P. 480–483.
- Ryazantsev D.Y., Myshkin M.Yu., Alferova V.A., Tsvetkov V.B., Shustova E.Y., Kamzeeva P.N., Kovalets P.V., Zaitseva E.R., Baleeva N.S., Zatsepin T.S., Baleeva N.S., Zatsepin T.S., Shenkarev Z.O., Baranov M.S., Kozlovskaya L.I., Aralov A.V. // Biomolecules 2021. V. 11. P. 1409. https://doi.org/10.3390/biom11101409
- Zenchenko A.A., Oslovsky V.E., Varizhuk I.V., Karpova E.V., Osolodkin D.I., Kozlovskaya L.I., Ishmukhametov A.A., Drenichev M.S. // Toxicol. In Vitro. 2022. V. 82. P. 105 355. https://doi.org/10.1016/j.tiv.2022.105355
 
				
			 
						 
						 
					 
						 
						 
									

 
  
  
  Enviar artigo por via de e-mail
			Enviar artigo por via de e-mail 

